News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NuVasive, Inc. (NUVA) to Sponsor the 5th Annual San Diego Festival of Science and Engineering Expo Day


3/19/2013 9:18:52 AM

SAN DIEGO, CA--(Marketwire - March 19, 2013) - NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to sponsor the 5th Annual San Diego Festival of Science and Engineering Expo Day on Saturday, March 23, 2013 from 10:00 a.m. to 5:00 p.m. at Petco Park, booth #HP16-17.

The San Diego Festival of Science and Engineering features interactive demonstrations and hands-on activities to inspire today's students to become tomorrow's science, technology, engineering, and math (STEM) innovators.

"Expo day is a great opportunity to showcase the importance of innovation," said Alex Lukianov, NuVasive Chairman and Chief Executive Officer. "Over the last century, the United States has been the world leader in developing new technologies to advance the quality of health care. It is critical that we continue to take the time to educate our children and young adults on how innovation not only dramatically advances the quality of health care, but how it changes patients' lives."

As a global leader in the spine industry, NuVasive is transforming health care by pioneering innovative surgical solutions to change spine surgery. Through technological advancements, NuVasive has successfully turned invasive spine surgery into the equivalent of outpatient surgery, with some patients often walking the same day of surgery. The ultimate focus is improving the lives of patients who suffer from debilitating back, neck or leg pain and is what drives the company to create products and procedures that truly make a difference.

Through investments in innovation, over 100,000 patients from all walks of life, including celebrities like Bill Walton, have benefitted from this new technology and superior clinical outcomes.

Basketball Hall-of-Famer and The Better Way Back® patient ambassador, Bill Walton underwent the NuVasive minimally disruptive technique called eXtreme Lateral Interbody Fusion (XLIF®) at age fifty-six after all other non-surgical options had been explored. After the procedure, he was amazed by the immediate relief from the unrelenting and excruciating nerve pain that had run through his back and down his legs for most of his adult life. Bill Walton went from contemplating suicide because of the debilitating pain to now living each day to the fullest and "getting his life back."

Bill Walton will be at the NuVasive booth from 10:30 a.m. to 12:00 p.m., signing autographs and discussing how the innovative XLIF procedure changed his life.

For more information on Expo Day please visit: http://www.sdsciencefestival.com/

About NuVasive

NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. The Company is the 4th largest player in the $8.2 billion global spine market. NuVasive's principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform's lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF®, NuVasive has built an entire spine franchise. With over 80 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus and dedication to outstanding service levels supported by a culture of Absolute Responsiveness®.

NuVasive cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties are described in NuVasive's press releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.


Investor Contact:
Stephan Ogilvie
VP, Corporate Development & Investor Relations
NuVasive, Inc.
201-322-6515
Email Contact

Media:
Nicole Collins
NuVasive, Inc.
858-909-1907
Email Contact


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES